Dexamethasone/Cytarabine/Oxaliplatin/Rituximab Regimen

Preferred Label : Dexamethasone/Cytarabine/Oxaliplatin/Rituximab Regimen;

NCIt synonyms : DHAX Plus Rituxan; Dexamethasone/Cytarabine/Oxaliplatin/Rituximab; DHAX-R; DHAX Plus Rituximab; Dexamethasone/Cytarabine/Oxaliplatin Plus Rituximab; R-DHAX;

NCIt related terms : R-DHAOx (rituximab-rixa); R-DHAOx (rituximab-abbs); R-DHAOx (rituximab-rite); R-DHAOx (rituximab-rixi); R-DHAOx; R-DHAOx (rituximab-arrx); R-DHAOx (rituximab-pvvr); R-DHAOx (rituximab-blit);

NCIt definition : A regimen consisting of dexamethasone, cytarabine, oxaliplatin and rituximab that can be used to treat diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma.;

NCI Metathesaurus CUI : CL1926315;

Codes from synonyms : 128576; 128419; 128105; 128733; 127948; 128262; 16299; 127791;

Details

Origin ID

C204002;

UMLS CUI

C5907833;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cytarabine [NCIt concept]
- Dexamethasone [NCIt concept]
- Oxaliplatin [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients